MaaT Pharma Announces Initiation of Coverage of its Stock by Kepler Cheuvreux Lyon, France, January…
MaaT PharmaJanuary 27, 2023
MaaT Pharma: Half-year Report on Liquidity Contract With the Brokerage Firm Kepler Cheuvreux Lyon, France,…
MaaT PharmaJanuary 9, 2023
Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital…
MaaT PharmaJanuary 6, 2023
MaaT Pharma Presents Promising Detailed Results from Completed Phase 1b Trial with MaaT033 at the…
MaaT PharmaDecember 11, 2022
MaaT Pharma Presents Compelling Consolidated MaaT013 Clinical Data at the 64th ASH Annual Meeting Oral…
MaaT PharmaDecember 10, 2022
MaaT Pharma To Webcast Investor Meeting in Conjunction with ASH 2022 Conference MaaT Pharma will…
MaaT PharmaNovember 29, 2022
MaaT Pharma Reports Cash and Revenues for Third Quarter 2022 As of September 30, 2022,…
MaaT PharmaNovember 8, 2022
MaaT Pharma Announces Participation in Scientific and Investor Conferences in November Lyon, France, November 7th, 2022,…
MaaT PharmaNovember 7, 2022
MaaT Pharma Announces Oral and Poster Presentations at the 64th American Society of Hematology (ASH)…
MaaT PharmaNovember 3, 2022
